Stay current with the FDA’s latest classification and compliance requirements for monitors designed to detect opioid-induced impairment of oxygenation. This course delivers a precise breakdown of the new Class II classification, special controls, and actionable compliance steps for manufacturers and stakeholders. Learn about clinical and non-clinical data standards, software and hardware requirements, usability, biocompatibility, safety, labeling, and the critical 510(k) premarket notification process. Ensure your devices meet FDA requirements to support patient safety and maintain market access.
In this course you will learn the following:
* Understand the FDA’s classification process for new medical devices, specifically the De Novo pathway.
* Identify the key requirements and special controls for monitors for opioid induced impairment of oxygenation.
* Implement the necessary steps to ensure compliance with the new rule.
* Recognize the legal and regulatory consequences of failing to comply with the final order.
